CON vs. HIMS, OPCH, GH, RDNT, SHC, SGRY, BTSG, PRVA, WGS, and LFST
Should you be buying Concentra Group Holdings Parent stock or one of its competitors? The main competitors of Concentra Group Holdings Parent include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), GeneDx (WGS), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.
Concentra Group Holdings Parent vs.
Concentra Group Holdings Parent (NYSE:CON) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.
Hims & Hers Health received 29 more outperform votes than Concentra Group Holdings Parent when rated by MarketBeat users. However, 87.50% of users gave Concentra Group Holdings Parent an outperform vote while only 37.07% of users gave Hims & Hers Health an outperform vote.
Concentra Group Holdings Parent has higher revenue and earnings than Hims & Hers Health. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Hims & Hers Health had 18 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 34 mentions for Hims & Hers Health and 16 mentions for Concentra Group Holdings Parent. Concentra Group Holdings Parent's average media sentiment score of 1.12 beat Hims & Hers Health's score of 0.72 indicating that Concentra Group Holdings Parent is being referred to more favorably in the media.
Concentra Group Holdings Parent presently has a consensus target price of $28.50, indicating a potential upside of 32.61%. Hims & Hers Health has a consensus target price of $37.31, indicating a potential downside of 0.16%. Given Concentra Group Holdings Parent's stronger consensus rating and higher possible upside, analysts clearly believe Concentra Group Holdings Parent is more favorable than Hims & Hers Health.
Hims & Hers Health has a net margin of 8.19% compared to Concentra Group Holdings Parent's net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Concentra Group Holdings Parent's return on equity.
Summary
Hims & Hers Health beats Concentra Group Holdings Parent on 9 of the 17 factors compared between the two stocks.
Get Concentra Group Holdings Parent News Delivered to You Automatically
Sign up to receive the latest news and ratings for CON and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Concentra Group Holdings Parent Competitors List
Related Companies and Tools
This page (NYSE:CON) was last updated on 3/25/2025 by MarketBeat.com Staff
